Valued at $51.8M at its later-stage round, Nov 2025. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch PhotoPharmics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
PhotoPharmics funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2023 | Early Stage VC | $26.2M | ▮ | ▮ |
| Dec 2020 | Seed Round | $2.5M | ▮ | ▮ |
| Sep 2019 | Early Stage VC | $6.6M | ▮ | ▮ |
| Feb 2017 | Debt | $2.7M | ▮ | ▮ |
| Jan 2017 | Seed Round | $2.3M | ▮ | ▮ |
| Jun 2015 | Debt | $2.1M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
PhotoPharmics valuation
PhotoPharmics was valued at $51.8 million at its later-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has PhotoPharmics raised?
PhotoPharmics has raised $50.9 million across 8 recorded rounds since 2012. The largest was a $6.6 million early-stage round in Sep 2019; the most recent was a $26.2 million early-stage round in Oct 2023.
PhotoPharmics has filed 9 Form Ds with the SEC since 2012, most recently in Apr 2025 ($23.9 million sold to 27 investors).
How PhotoPharmics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PhotoPharmics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about PhotoPharmics
- What is PhotoPharmics worth?
- PhotoPharmics is valued at $51.8M as of Oct 2026. Valued at $51.8M at its later-stage round, Nov 2025. Nothing has traded since.
- How much has PhotoPharmics raised?
- PhotoPharmics has raised $50.9M in total funding across 8 recorded rounds.
- When did PhotoPharmics last raise?
- PhotoPharmics last raised in Oct 2023 (Early Stage VC), raising $26.2M.